Going forward, mouse models with LRRK2 knockin mutation incorporate genetic susceptibility and aging to model PD pathogenesis and can be very useful in the study of the in vivo effects of LRRK2 kinase inhibition [108, 109]. The gene discussed is LRRK2; the disease is Parkinson disease.